Published in Am J Prev Med on April 01, 2010
Robotic Sock Technology for Prevention of Deep Vein Thrombosis and Joint Contracture | NCT03068338
DOAC ADRs Retrospective Study on Genetic Variations (DARES1) | NCT04580589
Novel genetic predictors of venous thromboembolism risk in African Americans. Blood (2016) 1.43
Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One (2011) 1.43
Treatment options for venous thromboembolism: lessons learnt from clinical trials. Thromb J (2014) 0.95
Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines. J Korean Med Sci (2014) 0.92
Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. Thromb Res (2011) 0.88
Update on Edoxaban for the Prevention and Treatment of Thromboembolism: Clinical Applications Based on Current Evidence. Adv Hematol (2015) 0.84
The role of molecular imaging in diagnosis of deep vein thrombosis. Am J Nucl Med Mol Imaging (2014) 0.84
Validity of Using Inpatient and Outpatient Administrative Codes to Identify Acute Venous Thromboembolism: The CVRN VTE Study. Med Care (2016) 0.83
Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. Thromb Res (2014) 0.82
Hospitalizations of adults ≥60 years of age with venous thromboembolism. Clin Appl Thromb Hemost (2013) 0.82
Increased risk of venous thromboembolism is associated with genetic variation in heme oxygenase-1 in Blacks. Thromb Res (2012) 0.81
Public health surveillance of nonmalignant blood disorders. Am J Prev Med (2014) 0.81
High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites. Ethn Dis (2014) 0.79
A microstructurally inspired damage model for early venous thrombus. J Mech Behav Biomed Mater (2015) 0.79
Neural hypernetwork approach for pulmonary embolism diagnosis. BMC Res Notes (2015) 0.79
Length of Stay Comparison between Rivaroxaban and Warfarin in the Treatment of Pulmonary Embolism: Results from a Real-World Observational Cohort Study. Thrombosis (2015) 0.78
Shorter Hospital Stays and Lower Costs for Rivaroxaban Compared With Warfarin for Venous Thrombosis Admissions. J Am Heart Assoc (2016) 0.78
Noninvasive thrombolysis using microtripsy: a parameter study. IEEE Trans Ultrason Ferroelectr Freq Control (2015) 0.78
Concise total synthesis of (±)-actinophyllic acid. Tetrahedron (2014) 0.78
Effectiveness and safety of expanded perioperative thromboprophylaxis in complex gynecologic surgery. Gynecol Oncol (2015) 0.78
A preliminary study of inherited thrombophilic risk factors in different clinical manifestations of venous thromboembolism in central Iran. Indian J Med Res (2015) 0.78
Venous thromboembolism in medical patients during hospitalisation and 3 months after hospitalisation: a prospective observational study. BMJ Open (2016) 0.78
Preoperative Chemoprophylaxis Is Safe in Major Oncology Operations and Effective at Preventing Venous Thromboembolism. J Am Coll Surg (2015) 0.77
Venous thromboembolism risk and prophylaxis in the acute hospital care setting: report from the ENDORSE study in Egypt. Thromb J (2012) 0.77
Whole blood gene expression profiles distinguish clinical phenotypes of venous thromboembolism. Thromb Res (2015) 0.77
Association between hospital imaging use and venous thromboembolism events rates based on clinical data. Ann Surg (2014) 0.77
Economic evaluation of different screening alternatives for patients with clinically suspected acute deep vein thrombosis. Biochem Med (Zagreb) (2013) 0.77
Histotripsy Thrombolysis on Retracted Clots. Ultrasound Med Biol (2016) 0.76
Association of Traditional Cardiovascular Risk Factors with Venous Thromboembolism: An Individual Participant Data Meta-analysis of Prospective Studies. Circulation (2016) 0.76
Systems Analysis of Thrombus Formation. Circ Res (2016) 0.76
Efficacy of histotripsy combined with rt-PA in vitro. Phys Med Biol (2016) 0.76
Associations of Trauma Exposure and Posttraumatic Stress Symptoms With Venous Thromboembolism Over 22 Years in Women. J Am Heart Assoc (2016) 0.76
Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies. Patient Prefer Adherence (2016) 0.75
In vitro and in vivo characterization of a reversible synthetic heparin analog. Thromb Res (2015) 0.75
Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients. Cancer Invest (2016) 0.75
Association of Homozygous Thrombophilia Polymorphisms and Venous Thromboembolism in Shahrekord, Iran. Tanaffos (2016) 0.75
Invited Commentary: The masquerading pulmonary embolism: why a high index of suspicion remains even today. Proc (Bayl Univ Med Cent) (2015) 0.75
Quantitative Systems Pharmacology Model to Predict the Effects of Commonly Used Anticoagulants on the Human Coagulation Network. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
Improved Stability of Proline-Derived Direct Thrombin Inhibitors through Hydroxyl to Heterocycle Replacement. ACS Med Chem Lett (2015) 0.75
Venous thromboembolism prophylaxis in hospitalized elderly patients: Time to consider a 'MUST' strategy. J Geriatr Cardiol (2011) 0.75
Platelets and platelet adhesion molecules: novel mechanisms of thrombosis and anti-thrombotic therapies. Thromb J (2016) 0.75
Oestrogen and anti-androgen therapy for transgender women. Lancet Diabetes Endocrinol (2016) 0.75
Pulmonary embolism in non-brain tumor patients after surgery-a retrospective study in China. World J Surg Oncol (2017) 0.75
The Association between Residence Floor Level and Cardiovascular Disease: The Health and Environment in Oslo Study. J Environ Public Health (2016) 0.75
Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers. Neuropsychiatr Dis Treat (2015) 0.75
The National Center on Birth Defects and Developmental Disabilities: past, present, and future. Am J Prev Med (2012) 0.75
Considerations for Imaging the Inferior Vena Cava (IVC) with/without IVC Filters. Semin Intervent Radiol (2016) 0.75
Assessment of Direct Oral Anticoagulant Prescribing and Monitoring Pre- and Post-Implementation of a Pharmacy Protocol at a Community Teaching Hospital. Hosp Pharm (2017) 0.75
Unloading of right ventricle and clinical improvement after ultrasound-accelerated thrombolysis in patients with submassive pulmonary embolism. Case Rep Med (2014) 0.75
Differential co-expression analysis of venous thromboembolism based on gene expression profile data. Exp Ther Med (2016) 0.75
PURLs: An alternative to warfarin for patients with PE. J Fam Pract (2012) 0.75
An Unusual Endovascular Therapeutic Approach for a Rare Case of May-Thurner Syndrome. Am J Case Rep (2017) 0.75
Robotic-Assisted Inferior Vena Cava Filter Retrieval. Methodist Debakey Cardiovasc J (2017) 0.75
Population-specific single-nucleotide polymorphism confers increased risk of venous thromboembolism in African Americans. Mol Genet Genomic Med (2016) 0.75
Non-invasive Thrombolysis Using Microtripsy in a Porcine Deep Vein Thrombosis Model. Ultrasound Med Biol (2017) 0.75
The role of thrombolytic therapy in pulmonary embolism. Blood (2015) 0.75
Pathogenesis of Thromboembolism and Endovascular Management. Thrombosis (2017) 0.75
Genetic association of PROC variants with pulmonary embolism in Northern Chinese Han population. Springerplus (2016) 0.75
Pediatric Hospital Acquired Venous Thromboembolism. Front Pediatr (2017) 0.75
Assessing the causal relationship between obesity and venous thromboembolism through a Mendelian Randomization study. Hum Genet (2017) 0.75
Anemia is not a risk factor for developing pulmonary embolism. Am J Emerg Med (2016) 0.75
A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science (2007) 18.96
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86
Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science (2005) 9.04
A pharmacogenetic versus a clinical algorithm for warfarin dosing. N Engl J Med (2013) 7.09
Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med (2010) 5.23
Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci U S A (2007) 3.58
Effect of escitalopram on mental stress-induced myocardial ischemia: results of the REMIT trial. JAMA (2013) 3.48
Clinical practice. Heparin-induced thrombocytopenia. N Engl J Med (2006) 3.11
Comparative effectiveness of warfarin and new oral anticoagulants for the management of atrial fibrillation and venous thromboembolism: a systematic review. Ann Intern Med (2012) 3.04
Effects of red-cell storage duration on patients undergoing cardiac surgery. N Engl J Med (2015) 3.03
RNA aptamers as reversible antagonists of coagulation factor IXa. Nature (2002) 2.73
Comparison of characteristics from White- and Black-Americans with venous thromboembolism: a cross-sectional study. Am J Hematol (2010) 2.26
Postpartum venous thromboembolism: incidence and risk factors. Obstet Gynecol (2014) 2.21
Evidence for the transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates in the era of nucleic acid test screening. Transfusion (2012) 2.19
Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. Ann Intern Med (2013) 2.15
The relative effects of abciximab and tirofiban on platelet inhibition and C-reactive protein during coronary intervention. J Invasive Cardiol (2010) 2.10
Is polycystic ovary syndrome another risk factor for venous thromboembolism? United States, 2003-2008. Am J Obstet Gynecol (2012) 2.03
Association between novel oxidative stress markers and C-reactive protein among adults without clinical coronary heart disease. Atherosclerosis (2005) 2.02
Sickle cell trait and the risk of venous thromboembolism among blacks. Blood (2007) 1.95
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol (2012) 1.85
Cryptogenic stroke in relation to genetic variation in clotting factors and other genetic polymorphisms among young men and women. Stroke (2002) 1.63
Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopenia. Thromb Haemost (2008) 1.61
Aspirin exposure reveals novel genes associated with platelet function and cardiovascular events. J Am Coll Cardiol (2013) 1.61
The relationship between plasma levels of oxidized and reduced thiols and early atherosclerosis in healthy adults. J Am Coll Cardiol (2006) 1.59
Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia. Blood (2010) 1.55
Trends in in-hospital deaths among hospitalizations with pulmonary embolism. Arch Intern Med (2012) 1.53
Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia. Anesth Analg (2009) 1.49
Impact of venous thromboembolism and anticoagulation on cancer and cancer survival. J Clin Oncol (2009) 1.45
Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients. Nephrol Dial Transplant (2012) 1.41
Randomized trial of physician alerts for thromboprophylaxis after discharge. Am J Med (2013) 1.39
Blockade of tissue factor: treatment for organ injury in established sepsis. Am J Respir Crit Care Med (2003) 1.38
Assays for measuring rivaroxaban: their suitability and limitations. Ther Drug Monit (2010) 1.36
Prevalence and clinical characteristics of mental stress-induced myocardial ischemia in patients with coronary heart disease. J Am Coll Cardiol (2013) 1.34
Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infect Immun (2002) 1.33
Blockade of tissue factor-factor X binding attenuates sepsis-induced respiratory and renal failure. Am J Physiol Lung Cell Mol Physiol (2005) 1.31
Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease. Blood (2012) 1.26
Depressive symptoms and mental stress-induced myocardial ischemia in patients with coronary heart disease. Psychosom Med (2013) 1.24
Oxidative stress is associated with impaired arterial elasticity. Atherosclerosis (2011) 1.23
High incidence of antibodies to protamine and protamine/heparin complexes in patients undergoing cardiopulmonary bypass. Blood (2013) 1.16
Endothelial function and aminothiol biomarkers of oxidative stress in healthy adults. Hypertension (2008) 1.15
Seroepidemiologic survey of epidemic cholera in Haiti to assess spectrum of illness and risk factors for severe disease. Am J Trop Med Hyg (2013) 1.14
Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood (2012) 1.12
Retracted Gene-expression patterns predict phenotypes of immune-mediated thrombosis. Blood (2005) 1.12
Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost (2012) 1.06
Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Blood (2004) 1.06
Clinical and laboratory diagnosis of von Willebrand disease: a synopsis of the 2008 NHLBI/NIH guidelines. Am J Hematol (2009) 1.05
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. PLoS One (2012) 1.04
Coagulation and inflammation in acute lung injury. Thromb Haemost (2002) 1.03
Hypercoagulable states and antithrombotic strategies in recurrent vascular access site thrombosis. J Vasc Surg (2003) 1.02
Cytokines in Mycoplasma pneumoniae infections. Cytokine Growth Factor Rev (2004) 1.02
Venous thromboembolic disease. J Natl Compr Canc Netw (2013) 1.01
Antihuman factor V antibodies after use of relatively pure bovine thrombin. Ann Thorac Surg (2005) 1.01
Time-dependent changes in non-COX-1-dependent platelet function with daily aspirin therapy. J Thromb Thrombolysis (2012) 1.00
Heparin modifies the immunogenicity of positively charged proteins. Blood (2010) 1.00
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl (2009) 1.00
The kaolin-activated Thrombelastograph predicts bleeding after cardiac surgery. J Cardiothorac Vasc Anesth (2006) 0.98
Venous thromboembolic disease. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2006) 0.98
Associations of depressive symptoms, trait hostility, and gender with C-reactive protein and interleukin-6 response after emotion recall. Psychosom Med (2010) 0.98
Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project. J Am Coll Cardiol (2007) 0.97
Hormonal contraception, sickle cell trait, and risk for venous thromboembolism among African American women. Am J Obstet Gynecol (2009) 0.96
Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection. Infect Immun (2003) 0.96
Health care expenditures associated with venous thromboembolism among children. Thromb Res (2011) 0.96
Heparin-induced thrombocytopenia. Annu Rev Med (2010) 0.95
Coagulation abnormalities in patients with hip osteonecrosis. Orthop Clin North Am (2004) 0.95
Low-molecular-weight heparin for thromboprophylaxis in pregnant women with mechanical heart valves. J Matern Fetal Neonatal Med (2006) 0.93
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis. Am J Hematol (2002) 0.91
Interference in microsphere flow cytometric multiplexed immunoassays for human cytokine estimation. Cytokine (2007) 0.90
Fibrinogen gamma gene 3'-end polymorphisms and risk of venous thromboembolism in the African-American and Caucasian population. Thromb Haemost (2009) 0.90
Thrombophilias: when should we test and how does it help? Semin Respir Crit Care Med (2008) 0.90
Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific. Microb Pathog (2003) 0.89
Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009. Pediatr Infect Dis J (2013) 0.89
Hyperreactive platelet phenotypes: relationship to altered serotonin transporter number, transport kinetics and intrinsic response to adrenergic co-stimulation. Thromb Haemost (2012) 0.88
Whole blood gene expression analyses in patients with single versus recurrent venous thromboembolism. Thromb Res (2011) 0.88
Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. Clin Adv Hematol Oncol (2005) 0.87
Trends in venous thromboembolism-related hospitalizations, 1994-2009. Pediatrics (2012) 0.87
Antithrombotic therapy and invasive procedures. N Engl J Med (2013) 0.87
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw (2008) 0.87
Direct-to-patient expert system and home INR monitoring improves control of oral anticoagulation. J Thromb Thrombolysis (2007) 0.87
Human parvovirus B19 in young male patients with hemophilia A: associations with treatment product exposure and joint range-of-motion limitation. Transfusion (2004) 0.86
Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome. Brain Behav Immun (2012) 0.86
Vascular endothelium summary statement II: Cardiovascular disease prevention and control. Vascul Pharmacol (2006) 0.86
The impact of co-morbid conditions on family history of venous thromboembolism in Whites and Blacks. Thromb Res (2011) 0.86
The prevalence of the prothrombin gene variant C20209T in African-Americans and Caucasians and lack of association with venous thromboembolism. Thromb Res (2006) 0.86
Warfarin in antiphospholipid syndrome--time to explore new horizons. J Rheumatol (2005) 0.86
Thrombotic storm revisited: preliminary diagnostic criteria suggested by the thrombotic storm study group. Am J Med (2011) 0.85
Characterization of the hypercoagulable state in patients with sickle cell disease. Thromb Res (2012) 0.85
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial. J Thromb Thrombolysis (2011) 0.85
Acute chest syndrome is associated with single nucleotide polymorphism-defined beta globin cluster haplotype in children with sickle cell anaemia. Br J Haematol (2013) 0.85
Alternative methods of anticoagulation for dialysis-dependent patients with heparin-induced thrombocytopenia. Semin Dial (2003) 0.84
Developing public health surveillance for deep vein thrombosis and pulmonary embolism. Am J Prev Med (2011) 0.84
Contributions of Asn2198, Met2199, and Phe2200 in the factor VIII C2 domain to cofactor activity, phospholipid-binding, and von Willebrand factor-binding. Thromb Haemost (2003) 0.84
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemia. Br J Haematol (2012) 0.84
Antiphospholipid antibodies after surgical exposure to topical bovine thrombin. J Lab Clin Med (2002) 0.83
Quinapril, an ACE inhibitor, reduces markers of oxidative stress in the metabolic syndrome. Diabetes Care (2004) 0.83
Predictive accuracy of 29-comorbidity index for in-hospital deaths in US adult hospitalizations with a diagnosis of venous thromboembolism. PLoS One (2013) 0.83
Evidence for the continued transmission of parvovirus B19 in patients with bleeding disorders treated with plasma-derived factor concentrates. Transfusion (2013) 0.82